GLP-1 / Ozempic Claims
Ozempic & GLP-1 Drug Injuries
Last updated: November 3, 2026
GLP-1 medications including Ozempic, Wegovy, Mounjaro, and others have been linked to serious gastrointestinal injuries and vision loss. More than 4,000 claims were pending in federal court as of October 1, 2026.
GLP-1 receptor agonist medications — including Ozempic, Wegovy, Mounjaro, and Trulicity — have been linked to serious injuries including gastroparesis (stomach paralysis), bowel obstruction, pancreatitis, gallbladder disease, and NAION vision loss. Claims are split across two federal MDLs, and more than 4,000 were pending in the larger, MDL 3094, as of October 1, 2026. Bellwether trials are expected in late 2026 or early 2027. Attorneys handle these cases on a contingency fee basis — no cost unless you receive compensation.
Which Drugs Are Included
The following GLP-1 receptor agonist medications are included in the current litigation:
Ozempic
Semaglutide — manufactured by Novo Nordisk. Approved for type 2 diabetes.
Wegovy
Semaglutide — manufactured by Novo Nordisk. Approved for chronic weight management.
Mounjaro
Tirzepatide — manufactured by Eli Lilly. Approved for type 2 diabetes.
Saxenda
Liraglutide — manufactured by Novo Nordisk. Approved for chronic weight management.
Rybelsus
Semaglutide (oral) — manufactured by Novo Nordisk. Approved for type 2 diabetes.
Trulicity
Dulaglutide — manufactured by Eli Lilly. Approved for type 2 diabetes.
Qualifying Injuries
Two categories of injuries are currently the subject of federal litigation against GLP-1 drug manufacturers:
| Injury | Key Symptoms | Diagnosis | MDL |
|---|---|---|---|
| Gastroparesis | Severe nausea, vomiting, bloating, weight loss | Gastric emptying study (GES) | MDL 3094 |
| Bowel Obstruction | Severe cramping, distension, inability to pass stool | CT scan, X-ray | MDL 3094 |
| Pancreatitis | Severe abdominal pain, nausea, elevated lipase | Blood test (lipase/amylase), CT scan | MDL 3094 |
| Gallbladder Disease | Right-side abdominal pain, nausea, jaundice | Ultrasound, HIDA scan | MDL 3094 |
| NAION (Vision Loss) | Sudden painless vision loss, typically one eye | Ophthalmologic exam, OCT imaging | MDL 3163 |
Gastrointestinal Injuries
- Gastroparesis (stomach paralysis)
- Bowel obstruction / ileus
- Pancreatitis
- Gallbladder disease / removal
Vision Loss
- NAION (non-arteritic anterior ischemic optic neuropathy)
- Sudden vision loss or impairment
Current Litigation Status
GLP-1 injury lawsuits are currently consolidated in two separate multidistrict litigations (MDLs) in the Eastern District of Pennsylvania:
MDL 3094 — Gastrointestinal
Cases involving gastroparesis, bowel obstruction, pancreatitis, and other GI injuries. Cases consolidated in the Eastern District of Pennsylvania.
MDL 3163 — Vision Loss
Cases involving NAION and other vision loss injuries. Cases consolidated in the Eastern District of Pennsylvania.
Bellwether trials are expected in late 2026 or early 2027. No settlements have been reached yet — the litigation is in its early stages. The outcome of initial trials will likely shape how thousands of remaining cases are resolved.
Do You Qualify?
You may be eligible to file a GLP-1 injury claim if the following apply:
Used an FDA-Approved GLP-1 Medication
You were prescribed and used Ozempic, Wegovy, Mounjaro, Saxenda, Rybelsus, Trulicity, or another GLP-1 receptor agonist.
Diagnosed with a Qualifying Injury
You were diagnosed with gastroparesis, bowel obstruction, pancreatitis, gallbladder disease, NAION, or other serious injury after starting the medication.
Have Medical Documentation
You have medical records documenting your injury and its connection to GLP-1 medication use.
Not Already Represented
You are not currently represented by another attorney for this specific claim.
Check If You Qualify
Answer a few quick questions to find out if you may be eligible for a GLP-1 injury lawsuit.
Frequently Asked Questions
Which GLP-1 medications are included in the lawsuits?
The litigation covers multiple GLP-1 receptor agonist medications including Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Saxenda (liraglutide), Rybelsus (semaglutide), and Trulicity (dulaglutide). Both brand-name and generic versions may be included.
What injuries qualify for a GLP-1 lawsuit?
Qualifying injuries fall into two main categories: gastrointestinal injuries (gastroparesis, bowel obstruction, ileus, pancreatitis, gallbladder disease or removal) and vision loss (NAION — non-arteritic anterior ischemic optic neuropathy). The injury must have occurred after starting a GLP-1 medication.
How long do I have to file a claim?
The statute of limitations varies by state and can range from one to several years from the date of injury or discovery. Because deadlines vary and new information continues to emerge, it is important to have your case evaluated as soon as possible to preserve your legal rights.
What is the current status of the Ozempic litigation?
Gastrointestinal injury cases are consolidated in MDL 3094 in the Eastern District of Pennsylvania, and vision loss cases are in a separate MDL 3163 in the same court. More than 4,000 claims were pending in MDL 3094 alone as of October 1, 2026. Bellwether trials are expected in late 2026 or early 2027. No settlements have been reached yet.
Do I need to stop taking my medication to file a lawsuit?
Filing a lawsuit does not require you to stop taking your medication. Any decisions about your medical treatment should be made with your doctor. The lawsuit is about whether the manufacturer adequately warned about the risks, not about whether you should continue treatment.
What does it cost to file a claim?
There is no cost to you. Attorneys handling GLP-1 injury cases work on a contingency fee basis, meaning they only get paid if you receive compensation. The initial case review through NuLegal is completely free with no obligation.
Claims by Injury Type
GLP-1 medications have been linked to several serious conditions. Learn about each injury type and your legal options.
Gastroparesis
Stomach paralysis causing severe nausea, vomiting, and inability to digest food normally.
Learn moreVision Loss (NAION)
Non-arteritic anterior ischemic optic neuropathy — sudden, painless vision loss.
Learn moreBowel Obstruction
Intestinal blockage causing severe cramping, distension, and inability to pass stool.
Learn moreGallbladder Disease
Gallstones, cholecystitis, and gallbladder removal linked to GLP-1 medications.
Learn morePancreatitis
Pancreatic inflammation causing severe abdominal pain, nausea, and elevated enzymes.
Learn moreFiling Deadlines by State
Statutes of limitations vary by state. Select your state to see specific filing deadlines and legal information for GLP-1 injury claims.
Alabama
Injury 2 years · Product 2 years
Alaska
Injury 2 years · Product 2 years
Arizona
Injury 2 years · Product 2 years
Arkansas
Injury 3 years · Product 3 years
California
Injury 2 years · Product 2 years
Colorado
Injury 2 years · Product 2 years
Connecticut
Injury 2 years · Product 3 years
Delaware
Injury 2 years · Product 2 years
District of Columbia
Injury 3 years · Product 3 years
Florida
Injury 2 years · Product 4 years
Georgia
Injury 2 years · Product 2 years
Hawaii
Injury 2 years · Product 2 years
Idaho
Injury 2 years · Product 2 years
Illinois
Injury 2 years · Product 2 years
Indiana
Injury 2 years · Product 2 years
Iowa
Injury 2 years · Product 2 years
Kansas
Injury 2 years · Product 2 years
Kentucky
Injury 1 year · Product 1 year
Louisiana
Injury 2 years · Product 2 years 1 year if injured before July 1, 2024
Maine
Injury 6 years · Product 6 years
Maryland
Injury 3 years · Product 3 years
Massachusetts
Injury 3 years · Product 3 years
Michigan
Injury 3 years · Product 3 years
Minnesota
Injury 6 years · Product 4 years
Mississippi
Injury 3 years · Product 3 years
Missouri
Injury 5 years · Product 5 years
Montana
Injury 3 years · Product 3 years
Nebraska
Injury 4 years · Product 4 years
Nevada
Injury 2 years · Product 2 years
New Hampshire
Injury 3 years · Product 3 years
New Jersey
Injury 2 years · Product 2 years
New Mexico
Injury 3 years · Product 3 years
New York
Injury 3 years · Product 3 years
North Carolina
Injury 3 years · Product 3 years
North Dakota
Injury 6 years · Product 6 years
Ohio
Injury 2 years · Product 2 years
Oklahoma
Injury 2 years · Product 2 years
Oregon
Injury 2 years · Product 2 years
Pennsylvania
Injury 2 years · Product 2 years
Rhode Island
Injury 3 years · Product 3 years
South Carolina
Injury 3 years · Product 3 years
South Dakota
Injury 3 years · Product 3 years
Tennessee
Injury 1 year · Product 1 year
Texas
Injury 2 years · Product 2 years
Utah
Injury 4 years · Product 2 years
Vermont
Injury 3 years · Product 3 years
Virginia
Injury 2 years · Product 2 years
Washington
Injury 3 years · Product 3 years
West Virginia
Injury 2 years · Product 2 years
Wisconsin
Injury 3 years · Product 3 years
Wyoming
Injury 4 years · Product 4 years
Don't Wait
Statutes of limitations may limit how long you have to file. Get a free, no-obligation case review today to find out if you qualify for compensation.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.